Thermodynamic Operating System for Human Biology
Quantum need not be only Computing, there is also nature
We apply quantum concepts to nature events without the need of using actual Quantum Computer. QMantis replaces lagging structural imaging and brittle statistical AI with Predictive Computational Physics. By utilizing cloud-based API, we apply a proprietary Physics-Informed Neural Network (PINN) framework to model the gut microbiome as a thermodynamic energy landscape. This allows clinical diagnostic networks and pharma CROs to mathematically forecast the exact tipping point of mucosal barrier collapse weeks or months before systemic inflammation occurs.
The Statistical Trap
The $11.5B non-invasive diagnostic market relies on AI that simply counts bacterial abundances. These statistical models are inherently noisy, generating massive false-positive rates that force patients into expensive, invasive procedures like liver biopsies and colonoscopies.
Physics-Informed Diagnostics
We calculate the continuous tension between Protective Commensals and Pathogenic Drivers using a Time-Dependent Hamiltonian matrix. We calculate a "Stability Angle" (θ) that predicts systemic inflammatory collapse.
Multi-Indication Clinical Validation
Alzheimer's (MCI)
Limma-Voom Cohort Data
Healthy (Control)
42.84°
MCI Tipping Point
122.96°
Alzheimer's (AD)
139.15°
Violent >80° phase shift perfectly isolates pre-dementia cognitive impairment boundary.
Liver (NASH / NAFLD)
Loomba 2017 Cohort (N=86)
Healthy Baseline
22.13°
Fatty Liver (NAFL)
28.87°
NASH (Fibrosis)
59.75°
Massive 37° phase shift creates a highly actionable diagnostic window for hepatologists.
Colorectal Cancer
Zeller Cohort (N=114)
63.45%
Baseline ROC-AUC
Fisher’s Discriminant auto-tuner mathematically identified B. fragilis as the luminal driver over F. nucleatum.
Moat
IP Defensibility: Patents for System architecture and phase-shift cutoff thresholds filed with Indian Patent Office (2 Patents Pending).
Peer Review Validation: Core predictive computational frameworks peer-reviewed and accepted for presentation at major global forums, including WCOG 2026 and ESMO 2026.
Go-To-Market Strategy
QMantis scales via a high-margin B2B software delivery layer. Initially launching as a "Research Use Only" (RUO) platform-as-a-service model, we offer a tool to pre-screen and rescue failing Phase II clinical trials by filtering out patients who have already passed the thermodynamic tipping point.
Current Milestones:
1. Expanding Scientific Advisory Board (SAB)
2. Advancing Computational Engine from TRL 3 to TRL 5
Contact founder
rajesh@qmantisconsulting.com
Pune, Maharashtra
Legal Disclaimer
The information provided by QMantis Consulting LLP ("we," "us," or "our") on this website is for general informational and academic purposes only. All information on the site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability, or completeness of any information on the site. Under no circumstance shall we have any liability to you for any loss or damage of any kind incurred as a result of the use of the site or reliance on any information provided on the site. Your use of the site and your reliance on any information on the site is solely at your own risk. This site may contain links to other websites or content belonging to or originating from third parties. Such external links are not investigated, monitored, or checked for accuracy, adequacy, validity, reliability, availability, or completeness by us. We do not warrant, endorse, guarantee, or assume responsibility for the accuracy or reliability of any information offered by third-party websites linked through the site.